Conformis Reports Second Quarter 2021 Financial Results
04 août 2021 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
14 juil. 2021 17h45 HE
|
Conformis, Inc.
BILLERICA, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
18 mai 2021 08h15 HE
|
Conformis, Inc.
BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
12 mai 2021 18h10 HE
|
Conformis, Inc.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Reports First Quarter 2021 Financial Results
05 mai 2021 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
07 avr. 2021 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
01 mars 2021 17h45 HE
|
Conformis, Inc.
BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
12 févr. 2021 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
11 févr. 2021 16h01 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
21 janv. 2021 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...